We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mirion Technologies Inc | NYSE:MIR | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.02 | -0.18% | 10.86 | 10.99 | 10.64 | 10.91 | 1,135,560 | 01:00:00 |
Mirion’s Chief Executive Officer, Thomas Logan, will reassume responsibilities of Medical Group President until permanent successor is named
Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that Michael Rossi has informed the Company of his decision to resign as Medical Group President, effective November 1, 2023, in order to assume a CEO role at another public company.
Mirion’s Chief Executive Officer, Thomas Logan, will reassume the responsibilities of Medical Group President until a permanent successor is named. Mr. Logan had previously served as acting Medical Group President through much of 2022.
“Mike has been a valued member of the Mirion executive team for the last year, and we are grateful for his contributions,” said Mr. Logan. “All of us at Mirion wish Mike well as he takes this next step in his career as a public company CEO.”
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231018343266/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Erin Schesny media@mirion.com
1 Year Mirion Technologies Chart |
1 Month Mirion Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions